Advanced Biomed Inc. ADVB
1.90 USD -0.20 (-9.62%)
Nov 5, 2026, 11:33 AM EST
1.84 Day range 2.17
1.84 52-week range 24.23
- YTD
- -67.50%
- 1 year
- -78.58%
Financial health
Altman Z-Score
-0.35 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A+5 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 3
- P/B 5
Valuation
P/E 0.9×
FY 2021 5y median -261× FY 2026
P/S 45.6×
FY 2021 5y median 0.0× FY 2026
P/B 0.5×
FY 2021 5y median 297× FY 2026
P/FCF -3.0×
FY 2021 5y median -504× FY 2026
EV/EBITDA -0.9×
FY 2021 5y median -264× FY 2026
EV/Sales 42.9×
FY 2021 5y median 0.0× FY 2026
FCF Yield -33.4%
FY 2021 5y median -0.2% FY 2026
Profitability
Gross Margin -4883.8%
FY 2021 5y median 0.0% FY 2026
Operating Margin -4883.8%
FY 2021 5y median 0.0% FY 2026
Net Margin 5231.3%
FY 2021 5y median 0.0% FY 2026
ROE 54.4%
FY 2021 5y median -115.4% FY 2026
ROIC -50.6%
FY 2021 5y median -100.6% FY 2026
ROA 48.6%
FY 2021 5y median -60.0% FY 2026
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2026
Operating Income -106.3%
FY 2021 FY 2026
EPS (diluted) 3431.3%
FY 2021 FY 2026
Free Cash Flow -967.1%
FY 2021 FY 2026
Financial Health
Current Ratio 9.3×
FY 2021 5y median 1.7× FY 2026
Quick Ratio 9.3×
FY 2021 5y median 1.7× FY 2026
Debt / Equity 0.0×
FY 2021 5y median 0.1× FY 2026
Net Debt / EBITDA 0.1×
FY 2021 5y median 0.7× FY 2026
Interest Coverage -889×
FY 2021 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30